Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis

Benjamin D. Pollock; Curtis B. Storlie; Aaron J. Tande; Priya Sampathkumar

doi:10.1093/cid/ciac186

Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis

Benjamin D. Pollock, Curtis B. Storlie, Aaron J. Tande, Priya Sampathkumar

Research output: Contribution to journal › Article › peer-review

Abstract

We followed 106 349 primary care patients for 22 385 3099 person-days across 21 calendar months and documented 69 breakthrough coronavirus disease 2019 (COVID-19) hospitalizations: 65/102,613 (0.06%) among those fully vaccinated, 3/11 047 (0.03%) among those previously infected, and 1/7,313 (0.01%) among those with both statuses. These data give providers real-world context regarding breakthrough COVID-19 hospitalization risk.

Original language	English (US)
Pages (from-to)	1239-1241
Number of pages	3
Journal	Clinical Infectious Diseases
Volume	75
Issue number	7
DOIs	https://doi.org/10.1093/cid/ciac186
State	Published - Oct 1 2022

Keywords

COVID-19
breakthrough
natural immunity
vaccination

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciac186

Cite this

Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis. / Pollock, Benjamin D.; Storlie, Curtis B.; Tande, Aaron J. et al.
In: Clinical Infectious Diseases, Vol. 75, No. 7, 01.10.2022, p. 1239-1241.

Research output: Contribution to journal › Article › peer-review

@article{e4b41bcd1ac54cde84efec5be1c125ad,

title = "Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis",

abstract = "We followed 106 349 primary care patients for 22 385 3099 person-days across 21 calendar months and documented 69 breakthrough coronavirus disease 2019 (COVID-19) hospitalizations: 65/102,613 (0.06%) among those fully vaccinated, 3/11 047 (0.03%) among those previously infected, and 1/7,313 (0.01%) among those with both statuses. These data give providers real-world context regarding breakthrough COVID-19 hospitalization risk.",

keywords = "COVID-19, breakthrough, natural immunity, vaccination",

author = "Pollock, {Benjamin D.} and Storlie, {Curtis B.} and Tande, {Aaron J.} and Priya Sampathkumar",

year = "2022",

month = oct,

day = "1",

doi = "10.1093/cid/ciac186",

language = "English (US)",

volume = "75",

pages = "1239--1241",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis

AU - Pollock, Benjamin D.

AU - Storlie, Curtis B.

AU - Tande, Aaron J.

AU - Sampathkumar, Priya

PY - 2022/10/1

Y1 - 2022/10/1

N2 - We followed 106 349 primary care patients for 22 385 3099 person-days across 21 calendar months and documented 69 breakthrough coronavirus disease 2019 (COVID-19) hospitalizations: 65/102,613 (0.06%) among those fully vaccinated, 3/11 047 (0.03%) among those previously infected, and 1/7,313 (0.01%) among those with both statuses. These data give providers real-world context regarding breakthrough COVID-19 hospitalization risk.

AB - We followed 106 349 primary care patients for 22 385 3099 person-days across 21 calendar months and documented 69 breakthrough coronavirus disease 2019 (COVID-19) hospitalizations: 65/102,613 (0.06%) among those fully vaccinated, 3/11 047 (0.03%) among those previously infected, and 1/7,313 (0.01%) among those with both statuses. These data give providers real-world context regarding breakthrough COVID-19 hospitalization risk.

KW - COVID-19

KW - breakthrough

KW - natural immunity

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85139536350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139536350&partnerID=8YFLogxK

U2 - 10.1093/cid/ciac186

DO - 10.1093/cid/ciac186

M3 - Article

C2 - 35247261

AN - SCOPUS:85139536350

SN - 1058-4838

VL - 75

SP - 1239

EP - 1241

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 7

ER -

Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this